Travere
Rare Disease Therapeutics

Travere news and milestones

Travere: 17 headlines on record, 10 headlines in the last 90 days.

Data updated Nov 18, 2026 · Back to the company report
17Headlines
10In 90 days
0Milestones

Headlines

Sep 232026
Blog
The post Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI (sp…
Sep 232026
News · Pulse 2.0
Travere Therapeutics has announced that Bradley L. Campbell will become President and Chief Executive Officer on December 1, 2026, succeeding Eric Dube, Ph.D., who has decided to…
Sep 232026
News · YahooFinance
Travere Therapeutics (NasdaqGM:TVTX) announced a planned CEO and President transition effective December 1, 2026. Dr. Eric Dube will step down from his roles as CEO and President…
Sep 222026
News · YahooFinance
Travere Therapeutics has delivered a very large share price gain over the past few years, which naturally puts the focus on what investors are paying for its sales today. With th…
Sep 212026
Blog
The post Travere Therapeutics Announces Planned Chief Executive Officer Transition appeared first on Travere.
Sep 202026
News · The Globe and Mail
Tipranks Press Release.
Sources: the outlets named on each headline, each story once

How to cite

Travere, News. Alion, Nov 18, 2026. https://alion.io/company/travere/news

.json · .md · CC BY-SA 4.0